George Budwell
George Budwell, PhD, is a contributing Motley Fool biotechnology and technology analyst covering disruptive innovators in healthcare, defense, and artificial intelligence. He also writes on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer and a consultant for several life sciences hedge funds. Earlier in his career, he was an evolutionary biologist and completed postdoctoral fellowships at Kyoto University and Illinois State University. He holds a doctorate in evolutionary biology from Tulane University and a bachelor’s degree from Loyola University.
Recent Articles by George Budwell

1 No-Brainer Vanguard ETF to Buy Right Now

7 Growth Stocks I'm Buying Hand Over Fist Right Now

2 High-Yield Dividend Stocks to Buy for Passive Income

2 Unstoppable Tech Giants to Buy Right Now

3 Incredible Growth Stocks I'm Buying On the Dip

2 No-Brainer AI Stocks to Buy Right Now

Better Dividend Growth Stock: Costco vs. Visa

2 Cheap Tech Stocks I'm Buying Right Now

2 Value Stocks I'm Buying Right Now

Why Pfizer Is My Largest Healthcare Position

Is Quantum Computing Pioneer IonQ the Next Nvidia?

2 Incredible Growth Stocks I'm Buying Hand Over Fist

2 High-Quality Dividend Stocks to Buy Right Now

3 Essential AI Infrastructure Stocks to Buy Right Now
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.